G. Scott

发表

5-methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation.

A. Inga, P. Monti, G. Fronza, 1999, Mutation research.

Simple identification of dominant p53 mutants by a yeast functional assay.

R. Iggo, A. Inga, P. Monti, 1997, Carcinogenesis.

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients

D. Bishop, A. Kiltie, G. Scott, 2011, BMC Medical Genetics.

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia

M. Coffey, A. Melcher, G. Scott, 2015, Leukemia.

Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche

M. Coffey, A. Melcher, G. Scott, 2021, Journal for ImmunoTherapy of Cancer.

Ultraviolet-light induced p53 mutational spectrum in yeast is indistinguishable from p53 mutations in human skin cancer.

A. Inga, P. Monti, G. Fronza, 1998, Carcinogenesis.

Human homologue of ariadne promotes the ubiquitylation of translation initiation factor 4E homologous protein, 4EHP

G. Scott, A. Markham, P. Robinson, 2003, FEBS letters.

Epithelial cell ADAM17 activation by Helicobacter pylori: role of ADAM17 C-terminus and Threonine-735 phosphorylation.

G. Scott, P. Robinson, J. Crabtree, 2015, Microbes and infection.

Profiling killers; unravelling the pathways of human natural killer cell function.

G. Cook, G. Scott, J. Meade, 2008, Briefings in functional genomics & proteomics.

The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and facts.

A. Inga, P. Monti, G. Fronza, 2000, Mutation research.

Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy.

G. Scott, G. Cook, C. Parrish, 2015, Cellular immunology.

Immune dysfunction in multiple myeloma

G. Scott, G. Cook, C. Parrish, 2013 .

Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition

A. Melcher, R. Vile, H. Pandha, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.

Paul A. Bowles, G. Cook, G. Scott, 2010, The Biochemical journal.

Influences of Base Excision Repair Defects on the Lethality and Mutagenicity Induced by Me-lex, a Sequence-selective N3-Adenine Methylating Agent*

A. Inga, P. Monti, G. Fronza, 2002, The Journal of Biological Chemistry.

Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo

M. Coffey, A. Melcher, G. Cook, 2015, Clinical and experimental immunology.

Comparison of induced and cancer-associated mutational spectra using multivariate data analysis.

G. Scott, P. Burns, B. Manshian, 2008, Carcinogenesis.

Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21

A. Melcher, H. Pandha, K. Harrington, 2019, Journal of Immunotherapy for Cancer.

Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21

A. Melcher, H. Pandha, K. Harrington, 2019, Journal of Immunotherapy for Cancer.

Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.

G. Scott, A. Markham, P. Robinson, 2003, Molecular biology of the cell.

UCH‐L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

G. Scott, P. Robinson, H. Ardley, 2004, Journal of neurochemistry.

Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent

G. Scott, P. Selby, G. Cook, 2012, PloS one.

Relationship between DNA Methylation and Mutational Patterns Induced by a Sequence Selective Minor Groove Methylating Agent*

A. Inga, P. Monti, G. Fronza, 1999, The Journal of Biological Chemistry.

Detecting variable (V), diversity (D) and joining (J) gene segment recombination using a two-colour fluorescence system

G. Cook, G. Scott, E. D. de Wynter, 2010, Mobile DNA.

Potassium diazoacetate-induced p53 mutations in vitro in relation to formation of O6-carboxymethyl- and O6-methyl-2'-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer.

G. Scott, P. Burns, D. Shuker, 2006, Carcinogenesis.

Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes.

Paul A. Bowles, G. Cook, T. Rabbitts, 2014, Molecular immunology.

Effect of combined dexamethasone/lenalidomide therapy on NK cell-receptor levels in myeloma patients.

G. Scott, G. Cook, K. Cullen, 2011, Blood.

In vitro functional effects of XPC gene rare variants from bladder cancer patients

A. Kiltie, M. Churchman, T. Bishop, 2011, Carcinogenesis.

Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells.

C. Burton, A. Melcher, G. Scott, 2023, Molecular therapy oncolytics.

Combination Therapy with Reovirus and Immunomodulatory Drugs Induces Direct Oncolytic and Immune-Mediated Killing of Multiple Myeloma Cells and Overcomes Stromal-Mediated Microenvironmental Protection

M. Coffey, A. Melcher, G. Scott, 2014 .

Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.

G. Cook, G. Scott, E. Wilson, 2010, The Biochemical journal.

Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes.

Paul A. Bowles, G. Cook, T. Rabbitts, 2014, Molecular immunology.

Epithelial cell ADAM17 activation by Helicobacter pylori: role of ADAM17 C-terminus and Threonine-735 phosphorylation.

G. Scott, P. Robinson, J. Crabtree, 2015, Microbes and infection.